Streetbeat News

Stock Prices

AVTX

LXRX

PED

Insiders at Lexicon Pharmaceuticals, Avalo Therapeutics, and PEDEVCO have recently made significant stock purchases. Lexicon announced a $125 million public offering and concurrent private placement, Avalo posted a narrower-than-expected quarterly loss, and PEDEVCO expanded into Wyoming D-J Basin Codell Play.

Portfolio Pulse from Lisa Levin

June 21, 2023 | 12:56 pm

EVGN

Evogene's subsidiary Casterra signed a framework agreement with an oil & gas company to sell its castor seeds for sustainable biofuel production, with initial purchase orders of $9.1 million.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2023 | 12:56 pm

CDIO

Cardio Diagnostics announced the nationwide launch of PrecisionCHD, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2023 | 12:54 pm

MDXG

MiMedx Group Inc (NASDAQ: MDXG) announced a strategic realignment to focus on its Wound & Surgical business, suspending its Knee Osteoarthritis program and disbanding its Regenerative Medicine unit. The company expects one-time wind-down expenses of $5 million and an addition of $25 million of Adjusted EBITDA for FY23. MiMedx also raised its 2023 net sales growth outlook from low-double digits to mid-teens.

Portfolio Pulse from Vandana Singh

June 21, 2023 | 12:54 pm

DLTR

Dollar Tree, Inc. (NASDAQ:DLTR) forecasts an EPS of $10 or more in the fiscal year 2026, with significant available cash for capital allocation. The company reaffirms its outlook for Q2 and fiscal 2023, expecting Q2 net sales of $7 billion-$7.2 billion and FY23 net sales of $30 billion-$30.5 billion.

Portfolio Pulse from Nabaparna Bhattacharya

June 21, 2023 | 12:52 pm

OCEA

Ocean Biomedical's shares are trading higher following a share price target increase to $17.63 by Fundamental Research Corp, based on positive results from an independent study on glioblastoma tumor suppression, recent patents, and financing.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2023 | 12:51 pm

APAM

LC

NECB

NWFL

OXBR

The article lists the top 5 overbought financial stocks that could negatively impact portfolios in Q2, based on their RSI values. The stocks mentioned are Northeast Community Bancorp (NECB), Artisan Partners Asset Management (APAM), LendingClub Corporation (LC), Oxbridge Re Holdings Limited (OXBR), and Norwood Financial Corp. (NWFL).

Portfolio Pulse from Lisa Levin

June 21, 2023 | 12:49 pm

NIO

China announced a 520 billion yuan ($72.35 billion) package aimed at increasing auto demand, extending new energy vehicle (NEV) purchase tax exemptions. This has fueled a rally in Chinese EV stocks, including NIO Inc (NYSE:NIO), whose shares are trading higher.

Portfolio Pulse from Adam Eckert

June 21, 2023 | 12:47 pm

HUM

LEN

SHAK

XLV

CNBC's 'Halftime Report Final Trades' featured stock picks from various analysts, including Shake Shack (SHAK), Health Care Select Sector SPDR Fund (XLV), D.R. Horton (HUM), and Lennar Corporation (LEN). D.R. Horton reported better-than-expected sales, while Lennar raised its full-year outlook after strong Q2 results.

Portfolio Pulse from Lisa Levin

June 21, 2023 | 12:46 pm

DMAC

DiaMedica Therapeutics (NASDAQ:DMAC) has announced a $37.5 million private placement of 11,011,406 common shares at $3.40 per share. The proceeds will be used to fund clinical and product development activities for DM199, including the ReMEDy2 clinical trial. The FDA has also removed the clinical hold on the ReMEDy2 trial.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 12:42 pm